Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma
BURLINGAME, Calif.–(BUSINESS WIRE)– Ablexis, LLC announced today the expansion of the roster of licensees of its AlivaMab Mouse technology to include an additional top 15 pharmaceutical company. This perpetual, non-exclusive license provides the licensee with its own colony of AlivaMab Mouse and broad rights to use the AlivaMab Mouse for antibody drug discovery and development. […]
Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma Read More »